Regeneron Q1 2026 net income falls 10% to $727m

Thursday, April 30, 2026Salong DebbarmaView original

Regeneron Pharmaceuticals has reported GAAP net income of $727m for Q1 2026, down 10% from $809m in Q1 2025.

Read the full article on the original site.